Neuraxpharm Holdco SARL Sustainability Reports
A leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders.
Sector: Manufacturing
Country: Spain
Exchange: Unlisted
LEI: 213800B7FZR8424I4R22
3 reports from 2020 to 2025
